Your browser doesn't support javascript.
loading
Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer.
Hamada, Shohei; Ichiyasu, Hidenori; Ikeda, Tokunori; Inaba, Megumi; Kashiwabara, Kosuke; Sadamatsu, Tomoki; Sato, Nahoko; Akaike, Kimitaka; Okabayashi, Hiroko; Saruwatari, Koichi; Tomita, Yusuke; Saeki, Sho; Hirata, Naomi; Yoshinaga, Takeshi; Fujii, Kazuhiko.
Afiliação
  • Hamada S; Department of Respiratory Medicine, Kumamoto University Hospital, Faculty of Life Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Ichiyasu H; Department of Respiratory Medicine, Kumamoto University Hospital, Faculty of Life Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan. ichiyasu@kumamoto-u.ac.jp.
  • Ikeda T; Department of Clinical Investigation (Biostatistics), Kumamoto University Hospital, Kumamoto, Japan.
  • Inaba M; Division of Respiratory Medicine, Kumamoto Chuo Hospital, Kumamoto, Japan.
  • Kashiwabara K; Department of Respiratory Medicine, Kumamoto Regional Medical Center, Kumamoto, Japan.
  • Sadamatsu T; Department of Respiratory Medicine, Minamata City General Hospital and Medical Center, Minamata, Japan.
  • Sato N; Department of Respiratory Medicine, Kumamoto University Hospital, Faculty of Life Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Akaike K; Department of Respiratory Medicine, Kumamoto University Hospital, Faculty of Life Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Okabayashi H; Department of Respiratory Medicine, Kumamoto University Hospital, Faculty of Life Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Saruwatari K; Department of Respiratory Medicine, Kumamoto University Hospital, Faculty of Life Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Tomita Y; Department of Respiratory Medicine, Kumamoto University Hospital, Faculty of Life Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Saeki S; Department of Respiratory Medicine, Kumamoto University Hospital, Faculty of Life Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Hirata N; Division of Respiratory Medicine, Kumamoto Chuo Hospital, Kumamoto, Japan.
  • Yoshinaga T; Division of Respiratory Medicine, Kumamoto Chuo Hospital, Kumamoto, Japan.
  • Fujii K; Department of Respiratory Medicine, Kumamoto University Hospital, Faculty of Life Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
BMC Pulm Med ; 19(1): 72, 2019 Apr 02.
Article em En | MEDLINE | ID: mdl-30940113

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Doenças Pulmonares Intersticiais / Carcinoma Pulmonar de Células não Pequenas / Bevacizumab / Neoplasias Pulmonares Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: BMC Pulm Med Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Doenças Pulmonares Intersticiais / Carcinoma Pulmonar de Células não Pequenas / Bevacizumab / Neoplasias Pulmonares Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: BMC Pulm Med Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão